Cyient Limited — Q4 FY26
Cyient's D segment Q4 FY26 revenue was $163.5M (₹1,500 Cr), down 2.4% QoQ CC and 1.5% YoY CC, impacted by client budget delays and geopolitical headwinds in West Asia.
neutral
medium
✓ Verified against BSE filing
Claim Ledger
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
58%Questions answered2Evaded / deflected12Questions auditedMixedNumbers vs filing
Evasive
High priority
Quantify West Asia exposure in D business and potential headwinds.
Asked by Bhavik Meta, JP Morgan
Management gave no quantitative exposure, only qualitative 'not significant' without specifics.
no number givenvague qualitative statement
Read the exchange
Question
can you quantify the exposure to West Asia as a region in terms of the venues for the D business to get a sense of what could be the potential headwinds we could anticipate over the next couple of quarters?
Krishna Bodhanapu (CEO)
our direct exposure to waste Asia business is not significant. However we do work with some tier one EPC and companies which service the energy market and that is more of a project based exposure. So it's difficult to assess in terms of exact number but you can consider that it's not a significant portion of our business overall.
Declined
High priority
Details on Project Astro acquisition asset and vertical.
Asked by Bhavik Meta, JP Morgan
Management declined to provide any details, citing NDAs.
NDA citedrefused to share
Read the exchange
Question
this project Astro what you mentioned any color you can cover in terms of what kind of asset you're looking at and you know which vertical was this in
Krishna Bodhanapu (CEO)
Unfortunately I just say it's a very big transformative acquisition. It wouldn't be fair with all the NDAs in place to talk about any specifics because that will give away too much detail.
Answered
High priority
Dilution level for DM business liquidity raise.
Asked by Bhavik Meta, JP Morgan
Management gave a specific dilution range (10-12%) for the first raise.
Read the exchange
Question
if you do decide to go for a liquidity raise what kind of dilution are you happy to go with
Krishna Bodhanapu (CEO)
We won't dilute more than maybe 10 12% of the equity to start with and then depending on how the business evolves and the capital needs we'll look at it but the first equity raise won't be more than 10 12%.
Partial answer
High priority
Pipeline to revenue conversion timeline and delays.
Asked by Manish Agarwal, Trade Swift Group
Management explained the delay but did not provide a specific timeline for when delayed deals would convert.
no timeline for delayed deals
Read the exchange
Question
despite consistent commentium strong pipeline and account mining the revenue growth has been modest. So can you quantify pipeline to revenue conversion timeline and what specifically is delaying that conversion?
Sukamal (CFO)
it was not a pipeline conversion issue. It was an issue of three key customers delaying their start of program. ... our converted order intake or order book gets consumed to the extent of 75% within the first 9 months.
Answered
Medium priority
Reconciling buyback and fund raise for capital efficiency.
Asked by Manish Agarwal, Trade Swift Group
Management clearly explained the separate purposes: buyback for science, fund raise for semiconductor.
Read the exchange
Question
given that you are returning cash via buyback while also exploring a fund raise how do you reconcile these two actions from a capital efficiency standpoint?
Krishna Bodhanapu (CEO)
the fund raise is for science semiconductor ... the buyback is really because in science looking at our capital requirements ... the board felt that it was a good time to do a buyback ... we want to establish an independent value because we believe there is a huge value unlock in science semiconductor.
Partial answer
High priority
Outlook for strategic unit growth in Q1 and Q2.
Asked by Moes Chandani, Ambit
Management gave a qualitative target of 'flat' but no quantitative guidance or timeline beyond next quarter.
no specific numbersaspirational language
Read the exchange
Question
on the strategic unit business, this is a very sharp degrowth. Now looking at Q1 is the expectation that growth will you see continued degrowth ... or do you think that there'll be maybe a mild recovery going into Q1 and then some improvement in Q2
Sukamal (CFO)
we definitely would want to bring it back to as close as flat for next quarter ... that is what we are working towards.
Partial answer
High priority
Semiconductor revenue and margin outlook for FY27.
Asked by Moes Chandani, Ambit
Management gave a run rate target but no precise revenue or margin figures, and margins remain negative.
no exact revenue numberno margin percentage
Read the exchange
Question
with the semiconductors business now that you've completed the acquisition of Kinetic any sense in terms of where you see numbers for FI27 and also just a little bit in terms of what the strategy is ... how you see growth as well as margins evolving
Krishna Bodhanapu (CEO)
we will get to a hundred million kind run rate at least or hundred million kind of a number for this year. ... margins for the year will still be negative just because we are building the product portfolio.
Answered
High priority
Outlook for FY27 growth and 15% EBITDA margin target.
Asked by Moes Chandani, Ambit
Management reaffirmed the 15% EBITDA margin target by Q4 FY27 and gave a growth range.
Read the exchange
Question
in terms of your outlooks for FI27, you previously said that we wanted to reach say a 15% emit margin by 4Q of FI27. And is that outlook still there? And also any qualitative expectations that you can give in terms of how growth will look like in FI27
Sukamal (CFO)
we are aspiring for mid to high single-digit organic growth year-over-year. ... From a margin perspective, yes, we maintain the same. ... we do want to commit to the fact that we are still working towards those numbers and achieving those numbers.
Partial answer
High priority
When will EBITDA margins recover to 18% levels?
Asked by Madur Rati, CCIPL
Management shifted from EBITDA to EBIT and gave a target of 15% EBIT, not 18% EBITDA.
reframed to EBITno absolute EBITDA number
Read the exchange
Question
what exactly has been the pain point that our AITA margins are down from 18% in FI24 to like 13% this year ... when do you foresee us recouping the 1,300 crore that we did in FR24 or reaching around 18% AITA margins?
Sukamal (CFO)
if we are aspiring towards a 15% EBIT now by Q4 of FI that will translate almost 17 and a half% EBITDA anyway right so that's the goal we are working towards. ... we will try and get there by Q4 of FI27.
Partial answer
High priority
Dilution percentage and valuation for semiconductor stake sale.
Asked by Madur Rati, CCIPL
Management gave dilution percentage but no valuation, saying it's for investors to determine.
no valuation givendeferred to market
Read the exchange
Question
any ballpark dilution percentage that we are looking to dilute and also what kind of valuation are we looking at
Krishna Bodhanapu (CEO)
from a dilution perspective we will keep it in the 10% range to start with ... in terms of what percentage of science market cap now that's for our investors to determine ... our understanding or expectation is best case that it's a marginal value or a zero value but in reality the value is much higher.
Partial answer
Medium priority
Quantitative color on deal wins this quarter.
Asked by Rajas Jooshi, Chris Capital
Management gave a growth percentage but no absolute numbers or deal values.
no absolute order intake numberno deal value
Read the exchange
Question
could you please give some quantitative color especially some numbers if you may on the nature of our deals this quarter?
Sukamal (CFO)
we had a 23% growth in order intake over previous year. ... a significant portion of that growth came in Q4 ... quite a few of them were longer term as in 2 three years consolidation deals across various segments like aerospace, rail, connectivity.
Answered
Medium priority
Levers for margin expansion to 15% exit margin.
Asked by Rajas Jooshi, Chris Capital
Management listed specific levers: price hikes, automation, cost cutting, forex tailwinds.
Read the exchange
Question
on margins right so the walk to 15% kind of exit margin. If you could just expand on some of the levers that are at play which will support this margin expansion.
Sukamal (CFO)
we have a bunch of levers ... on the revenue side, price hikes ... on the cost side, delivering the same revenue using automation, AI ... a program we are running on to cut costs in administrative expenses ... tailwinds from forex etc.
Quantitative claims vs filed numbers
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| Aspire for mid to high single-digit organic growth in FY27 | 7% | 7.4% | Matches filing |
| 15% EBIT margin target by Q4 FY27 | 15% | 12% | Overstated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.